Dr. Reddy's Counts On U.S. Market For This Fiscal Year
This article was originally published in PharmAsia News
Executive Summary
India's Dr. Reddy's Laboratories plans to launch as many as 12 generic drugs in the United States during the current fiscal year, relying on the nation to be the firm's main growth source